This partnership, sponsored by the National Cancer Institute’s Center to Reduce Cancer Health Disparities, brings together many researchers from both North Carolina Central University (NCCU) and Duke and is developing infrastructure that targets translational cancer disparities research.
We are achieving our goals in several ways:
To find out more, or to request an application for C-REP, please contact us:
Donna Crabtree, PhD, Duke University Program Manager
Vince Chandler, MPA, NCCU Program Manager
Translational Research in Cancer Disparities
Cancer Research Education Program (C-REP)
The Cancer Disparities Translational Research Partnership has generated a variety of novel findings and publications, as well as media attention and coverage. Below is a small sampling of our program’s impact.
One of the primary goals of C-REP is to develop and implement tailored interventions to increase diversity and inclusion in clinical trials. We are providing resources and services to improve the quality, safety and efficiency, cost-effectiveness, and impact of clinical and translational research. By engaging in community outreach and education, we are adding samples to a biospecimen repository, which allows us to investigate pathological mechanisms in cancer disparities. Having a clearer understanding of the molecular characteristics of these diseases that disproportionately affect minorities will allow us to move forward into prospective clinical trials using rationally designed, targeted therapeutics.
Recipient Of The 2017 ACCC Innovator Award
Duke Cancer Institute is among 10 cancer centers named by the Association of Community Cancer Centers (ACCC) to receive its 2017 Innovator Award. Duke Cancer Institute, through the Office of Health Equity and Disparities, developed a five-step roadmap for conducting health assessments designed to reduce cancer disparities and improve population health through community partnerships. The program includes the development of an engaged and diverse community advisory council, robust and collaborative health assessments, programs and services, research priorities, aligned partnership programming and programmatic evaluations and outcome measures.
Duke Cancer Institute constellates the world-class resources of Duke University, Duke Health and the Duke Comprehensive Cancer Center into a collaborative powerhouse. We are poised to drive a paradigm shift in the way long-established cancer centers and institutes have been waging this war.Learn More